Themis Medicare Limited carries a market capitalization of 11.19B, placing it among publicly traded companies globally. Its enterprise value stands at 6.93B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.19B |
| Enterprise Value | 6.93B |
Themis Medicare Limited currently has 92.10M shares outstanding.
| Shares Outstanding | 92.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Themis Medicare Limited trades at a trailing price-to-earnings ratio of 531.73. The price-to-sales ratio is 1.78, and the price-to-book ratio stands at 66.04.
| PE Ratio | 531.73 |
| PS Ratio | 1.78 |
| PB Ratio | 66.04 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 2.02 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 109.27 |
Themis Medicare Limited maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.11, indicating elevated leverage, while an interest coverage ratio of -0.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.84 |
| Quick Ratio | 0.09 |
| Debt / Equity | 25.11 |
| Debt / EBITDA | -10.08 |
| Interest Coverage | -0.93 |
Themis Medicare Limited posts a return on equity of 0.83 and a return on invested capital of -1.19.
| Return on Equity (ROE) | 0.83 |
| Return on Assets (ROA) | 0.19 |
| Return on Invested Capital (ROIC) | -1.19 |
| Return on Capital Employed (ROCE) | 3.26 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.57 |
Over the trailing twelve months, Themis Medicare Limited has paid 7.85M in income taxes, reflecting an effective tax rate of 40.69.
| Income Tax | 7.85M |
| Effective Tax Rate | 40.69 |
Themis Medicare Limited's stock has declined approximately -3.81558% over the past 52 weeks. The 50-day moving average sits at 104.45, while the 200-day moving average is 101.35.
| Beta (5Y) | N/A |
| 52-Week Price Change | -3.81558% |
| 50-Day Moving Average | 104.45 |
| 200-Day Moving Average | 101.35 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Themis Medicare Limited generated 3.42B in revenue and converted that into 11.44M in net income, yielding earnings per share of 0.12. EBITDA reached -99.28M, while operating income came in at -99.28M.
| Revenue | 3.42B |
| Gross Profit | 2.13B |
| Operating Income | -99.28M |
| Pretax Income | 19.28M |
| Net Income | 11.44M |
| EBITDA | -99.28M |
| EBIT | -99.28M |
| Earnings Per Share (EPS) | 0.12 |
Themis Medicare Limited holds 155.61M in cash and equivalents against 1.00B in total debt, resulting in a net debt position of 955.53M. Total book value stands at 92.10M, with working capital of 1.39B providing operational flexibility.
| Cash & Cash Equivalents | 155.61M |
| Total Debt | 1.00B |
| Net Debt | 955.53M |
| Equity (Book Value) | 92.10M |
| Book Value Per Share | 1.00 |
| Working Capital | 1.39B |
Themis Medicare Limited operates with a gross margin of 62.17, reflecting its pricing power and cost economics. The operating margin of -2.90 and net profit margin of 0.33 provide insight into operational efficiency.
| Gross Margin | 62.17 |
| Operating Margin | -2.90 |
| Pretax Margin | 0.56 |
| Profit Margin | 0.33 |
| EBITDA Margin | -2.90 |
Themis Medicare Limited's most recent stock split took place on October 10, 2023 with a 1:10 split ratio.
| Last Split Date | 10/10/2023 |
| Split Ratio | 1:10 |
Themis Medicare Limited posts an Altman Z-Score of 2.63, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.63 |